Sterol_NN
dependent_JJ
LDL-receptor_NN
gene_NN
transcription_NN
in_IN
lymphocytes_NNS
from_IN
normal_JJ
and_CC
CML_NN
patients_NNS
._.

Sterol_NN
regulatory_JJ
element_NN
-LRB-_-LRB-
SRE_NN
-RRB-_-RRB-
has_VBZ
been_VBN
recognized_VBN
to_TO
regulate_VB
various_JJ
key_JJ
genes_NNS
coding_VBG
for_IN
especially_RB
low_JJ
density_NN
lipoprotein_NN
-LRB-_-LRB-
LDL_NN
-RRB-_-RRB-
-_:
receptor_NN
,_,
3-hydroxy-3-methylglutaryl_NN
coenzyme_NN
A_NN
-LRB-_-LRB-
HMG-CoA_NN
-RRB-_-RRB-
reductase_NN
and_CC
HMG-CoA_NN
synthase_NN
known_VBN
to_TO
play_VB
a_DT
crucial_JJ
role_NN
in_IN
the_DT
cholesterol_NN
feedback_NN
mechanism_NN
._.

The_DT
deranged_JJ
cholesterol_NN
feedback_NN
mechanism_NN
has_VBZ
been_VBN
widely_RB
recognized_VBN
in_IN
initiation_NN
as_RB
well_RB
as_IN
progression_NN
of_IN
various_JJ
types_NNS
of_IN
cancers_NNS
including_VBG
chronic_JJ
myeloid_JJ
leukemia_NN
-LRB-_-LRB-
CML_NN
-RRB-_-RRB-
._.

Consequently_RB
,_,
the_DT
present_JJ
study_NN
was_VBD
addressed_VBN
to_TO
understand_VB
this_DT
phenomenon_NN
and_CC
revealed_VBD
the_DT
existence_NN
of_IN
a_DT
unique_JJ
47_CD
kDa_NN
protein_NN
factor_NN
having_VBG
affinity_NN
for_IN
this_DT
SRE_NN
sequence_NN
in_IN
lymphocytes_NNS
from_IN
normal_JJ
subjects_NNS
as_RB
well_RB
as_IN
its_PRP$
absence_NN
in_IN
lymphocytes_NNS
from_IN
untreated_JJ
CML_NN
patients_NNS
._.

However_RB
,_,
this_DT
factor_NN
appeared_VBD
when_WRB
the_DT
CML_NN
patients_NNS
achieved_VBD
complete_JJ
hematological_JJ
remission_NN
-LRB-_-LRB-
CHR_NN
-RRB-_-RRB-
through_IN
alpha-interferon_NN
therapy_NN
._.

Further_RB
,_,
an_DT
inverse_JJ
relationship_NN
was_VBD
also_RB
observed_VBN
between_IN
sterol_NN
modulated_JJ
LDL-receptor_NN
gene_NN
transcription_NN
and_CC
the_DT
binding_VBG
affinity_NN
of_IN
this_DT
47_CD
kDa_NN
factor_NN
to_TO
the_DT
SRE_NN
sequence_NN
._.

Based_VBN
upon_IN
these_DT
results_NNS
we_PRP
propose_VBP
that_IN
alpha-interferon_NN
through_IN
its_PRP$
receptor_NN
initiates_VBZ
phosphatidic_JJ
acid_NN
dependent_JJ
signalling_NN
which_WDT
in_IN
turn_NN
regulates_VBZ
the_DT
affinity_NN
of_IN
47_CD
kDa_NN
sterol_NN
regulatory_JJ
element_NN
binding_NN
factor_NN
as_RB
well_RB
as_IN
LDL-receptor_NN
gene_NN
transcription_NN
in_IN
lymphocytes_NNS
from_IN
CML_NN
patients_NNS
._.

